John W. Higuchi, Director at Lipocine Inc. (LPCN), bought 40,000 shares at $2.03 ($81K) on 2026-04-07, disclosed to the SEC on 2026-04-07.
Open-market purchase of $81k LPCN by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Something here stands out, but not much.
| Filing → |
| LPCN | BUY | 2026-04-06 | $252K | — | Filing → |
| LPCN | SELL | 2021-01-04 | $9K | — | Filing → |
| LPCN | BUY | 2020-03-18 | $70K | — | Filing → |